MCRB vs XLE
Seres Therapeutics Inc (MCRB) versus Energy Select Sector SPDR® Fund (XLE) — a side-by-side from cached financials, not a winner call.
Seres Therapeutics Inc (MCRB) is a biotechnology company listed on US.
Energy Select Sector SPDR® Fund (XLE) common stock listed on US.
Latest reported MCRB revenue for 2026-06-30 was $1.1M. Net income was -$15.3M. MCRB currently screens at market cap $109.8M.
XLE does not have a complete income-statement cache yet.
MCRB currently screens at market cap $109.8M. XLE currently screens at market cap $0.
Not investment advice. Open the MCRB and XLE stock pages for the full models.
Not investment advice.